Drug Type Small molecule drug |
Synonyms BMS 823778, BMS823778 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18ClN3O |
InChIKeyPTIFVLOBVCIMKL-UHFFFAOYSA-N |
CAS Registry1140897-32-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque, Atherosclerotic | Phase 2 | - | 01 Apr 2014 | |
Hypertension | Phase 2 | United States | 01 Jul 2012 | |
Hypertension | Phase 2 | Colombia | 01 Jul 2012 | |
Hypertension | Phase 2 | Hungary | 01 Jul 2012 | |
Hypertension | Phase 2 | Puerto Rico | 01 Jul 2012 | |
Hypertension | Phase 2 | Sweden | 01 Jul 2012 | |
Obesity | Phase 2 | United States | 01 Jul 2012 | |
Obesity | Phase 2 | Colombia | 01 Jul 2012 | |
Obesity | Phase 2 | Hungary | 01 Jul 2012 | |
Obesity | Phase 2 | Puerto Rico | 01 Jul 2012 |